GHK-Cu and Hair Growth: What Does the Research Say?

Does GHK-Cu help hair growth? The published evidence is narrower than the claims attached to it. Most research on GHK-Cu and hair growth comes from cell culture and animals, and the one randomised human trial tested a copper-free version of the peptide combined with a second compound.

The term copper peptide hair growth covers three related molecules, and studies of one are often quoted as evidence for another. This article separates them and sets out each study behind claims about GHK-Cu for hair growth: the molecule tested, the model used and the point where the evidence stops.

River Peptides supplies the GHK-Cu peptide as a research compound for laboratory use only, not for human or veterinary use. Nothing below is medical or usage guidance.

Copper Peptide Hair Growth Research

GHK-Cu is the tripeptide glycyl-L-histidyl-L-lysine bound to a copper(II) ion. It occurs naturally in human plasma, saliva and urine. Our GHK-Cu deep dive covers its general biology, and a 2018 review by Pickart and Margolina summarises the gene-expression data linking it to tissue remodelling and repair.

Hair research draws on signals that copper tripeptides have been reported to influence in cultured cells. Earlier work on copper tripeptides, summarised in the introduction to the 2007 study by Pyo and colleagues, reported that in dermal fibroblasts the complex raised production of vascular endothelial growth factor (VEGF), which drives blood vessel growth, and lowered secretion of transforming growth factor-beta1 (TGF-beta1).

GHK-Cu, AHK-Cu and Copper-Free GHK Are Different Molecules

GHK-Cu starts with the amino acid glycine. AHK-Cu replaces glycine with alanine. Copper-free GHK is the same three amino acids without the copper ion. Hair studies have used each of them, and evidence for one does not transfer to another.

The 2007 follicle study on copper tripeptides used AHK-Cu, and the only randomised human trial used copper-free GHK. Both are covered below.

The studies fall into three groups, and the evidence sits on a ladder. In vitro studies use cells or tissue in a dish. Animal studies test a living body that is not human. Human studies are the only ones that show what happens in people.

Cell and Tissue Studies

Pyo and colleagues (Seoul National University, 2007) tested AHK-Cu on human hair follicles kept in organ culture and on cultured dermal papilla cells, the cells at the base of the follicle that direct its growth. At picomolar to nanomolar concentrations (10⁻¹² to 10⁻⁹ molar), AHK-Cu lengthened the cultured follicles and increased dermal papilla cell proliferation.

The follicles were kept outside the body, and the molecule was AHK-Cu, not GHK-Cu.

Animal Studies

Uno and Kurata (1993) reported that a copper-binding peptide designated PC1031 enlarged follicles on the back skin of fuzzy rats, with an effect similar to topical minoxidil. The abstract does not name the peptide as GHK-Cu; the site was body skin rather than scalp, and the species was a rat. The macaque results in the same paper concern minoxidil, diazoxide and a 5-alpha-reductase inhibitor, not the copper peptide.

Liu and colleagues (2023) built an ionic-liquid microemulsion to carry GHK-Cu into the skin of mice. The formulation improved local delivery about threefold and increased activation of the Wnt/beta-catenin pathway, a signalling route that regulates hair growth. The authors also examined growth factors such as VEGF. It is a mouse study focused on delivery and reports no human data.

Human Studies

Lee and colleagues (Kyungpook National University Hospital, 2016) ran a randomised, double-blind, six-month trial in 45 men with male pattern hair loss. All participants were men. Participants sprayed ALAVAX, a complex of 5-aminolevulinic acid (5-ALA) and copper-free GHK, on the scalp once daily at one of two strengths, or used a placebo.

Hair count in a 1 cm circle rose by 52.6 in the higher-strength group and 71.5 in the lower-strength group, against 9.6 with placebo. The lower-strength group therefore outperformed the higher-strength group. The significance values compare each active group with its own baseline. The only significant difference between groups at six months was the ratio of change for the lower strength against placebo. Hair length and thickness did not differ between groups, and no adverse events were reported.

Because 5-ALA forms part of the molecule, the result cannot be assigned to the peptide, and the authors described it as a possible complementary agent. We could not identify a published human trial of GHK-Cu alone for hair growth.

Why Delivery Limits What These Studies Can Show

Liu and colleagues describe topical delivery of GHK-Cu as a challenge that limits non-invasive use. A peptide has to cross the skin’s outer barrier before any cell-level finding could apply to a follicle. Cell studies bypass the skin, and the mouse formulation was engineered specifically to cross it, so a result in one setting does not predict a result in another.

How Does GHK-Cu Research Sit Alongside UK-Licensed Hair Loss Treatments?

GHK-Cu is not among the medicines licensed for pattern hair loss in the UK. The medicines licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for this use are topical minoxidil and, for men, finasteride 1 mg.

Cosmetic serums containing copper tripeptide-1 are sold as cosmetics, not medicines. Hair loss has several causes, and a GP is the first point of contact for identifying which applies. The NHS hair loss page explains when to seek advice.

How Do River Peptides Assess the Quality of a GHK-Cu Batch?

A copper complex adds a variable that a plain peptide does not: the compound must have the right sequence, the stated purity and the copper bound to it. Researchers check three things.

• Purity: high-performance liquid chromatography (HPLC) separates the peptide from related substances.
• Identity: mass spectrometry confirms the molecular weight matches the expected compound.
• Batch documentation: the batch ID on the label should match a certificate of analysis (CoA) for that batch.

River Peptides sends every batch to independent laboratories, including Janoshik Laboratories and Analiza Biatek, for HPLC and mass spectrometry before release. The quality system behind this is certified to ISO 9001 and ISO 14001. The certificate of analysis published on the GHK-Cu product page lists 99% purity by HPLC.

Read the independent testing process or browse the GHK-Cu research compound, supplied for laboratory research use only.

Buying GHK-Cu from River Peptides 

River Peptides supplies GHK-Cu as a lyophilised (freeze-dried) research compound for laboratory use only. We also offer a pre-mixed spray solution that delivers 0.1ml per actuation, containing 555mcg of the active copper compound. They are not for human or veterinary use, and they are not a hair or cosmetic product. Each batch is tested independently before release, and the batch ID on the label leads to its certificate of analysis. Browse our GHK-Cu peptides for research use only.

GHK-Cu and Hair Growth FAQs

Does GHK-Cu Help Hair Growth?

Published human evidence for GHK-Cu alone is lacking. Cell, animal and one small human trial on a related compound show activity in follicle biology, but none test GHK-Cu in people with hair loss. Research on other reported GHK-Cu benefits focuses mostly on skin and wound healing rather than GHK-Cu for hair growth.

What Do GHK-Cu Before and After Hair Photos Show?

A photo shows one person at two points in time. It cannot separate a peptide from lighting, styling or other treatments. Trials use fixed-site counts, such as the 1 cm circle in Lee 2016, and compare against placebo.

Is GHK-Cu the Same as the Copper Peptide in Hair Serums?

Cosmetic labels list GHK-Cu as copper tripeptide-1, and some serums use AHK-Cu instead. Formulation and regulation differ from product to product. River Peptides supplies unformulated research compounds for laboratory use, not hair or cosmetic products.

Is GHK-Cu Approved for Hair Loss in the UK?

No. It is not among the medicines licensed for pattern hair loss in the UK. Minoxidil and finasteride are the licensed options, and a GP is the first step for hair loss.

Can GHK-Cu Replace Minoxidil or Finasteride?

No published human trial that we could verify compares them. The minoxidil comparison in the copper peptide literature we reviewed rests on the 1993 rat study of a peptide not named as GHK-Cu.

What Is the Best Copper Peptide for Hair?

No copper peptide has been shown to grow hair in people, so no product can be ranked on that basis. Researchers can compare quality: purity by HPLC, identity by mass spectrometry, and a CoA matched to the batch.

How Long Do Hair Studies Last?

Lee 2016 ran for six months, with measurements at one, three and six months. Hair moves through growth and rest phases over months, so short studies capture little.